Skip to main content
  • AACR Publications
    • Cancer Discovery
    • Cancer Epidemiology, Biomarkers & Prevention
    • Cancer Immunology Research
    • Cancer Prevention Research
    • Cancer Research
    • Clinical Cancer Research
    • Molecular Cancer Research
    • Molecular Cancer Therapeutics

  • Register
  • Log in
Advertisement

Main menu

  • Home
  • About
    • The Journal
    • AACR Journals
    • Subscriptions
    • Permissions and Reprints
    • Reviewing
  • Articles
    • OnlineFirst
    • Current Issue
    • Past Issues
    • Focus on Computer Resources
    • 75th Anniversary
    • Meeting Abstracts
  • For Authors
    • Information for Authors
    • Author Services
    • Best of: Author Profiles
    • Submit
  • Alerts
    • Table of Contents
    • OnlineFirst
    • Editors' Picks
    • Citations
    • Author/Keyword
  • News
    • Cancer Discovery News
  • AACR Publications
    • Cancer Discovery
    • Cancer Epidemiology, Biomarkers & Prevention
    • Cancer Immunology Research
    • Cancer Prevention Research
    • Cancer Research
    • Clinical Cancer Research
    • Molecular Cancer Research
    • Molecular Cancer Therapeutics

User menu

  • Register
  • Log in

Search

  • Advanced search
Cancer Research
Cancer Research

Advanced Search

  • Home
  • About
    • The Journal
    • AACR Journals
    • Subscriptions
    • Permissions and Reprints
    • Reviewing
  • Articles
    • OnlineFirst
    • Current Issue
    • Past Issues
    • Focus on Computer Resources
    • 75th Anniversary
    • Meeting Abstracts
  • For Authors
    • Information for Authors
    • Author Services
    • Best of: Author Profiles
    • Submit
  • Alerts
    • Table of Contents
    • OnlineFirst
    • Editors' Picks
    • Citations
    • Author/Keyword
  • News
    • Cancer Discovery News
Poster Discussion Abstracts

Prognostic relevance of circulating tumor cells (CTCs) in peripheral blood of breast cancer patients before and after adjuvant chemotherapy – translational research program of the German SUCCESS-trial.

C Schindlbeck, B Rack, J Jueckstock, A Schneeweiss, E Thurner-Herrmanns, A Schneider, M Rezai, M Beckmann, K Pantel, W Lichtenegger, H Sommer, K Friese, W Janni and D Chatsiproios
C Schindlbeck
Dept. of Obstetrics and Gynecology, Ludwig-Maximilians-University, Munich, Germany
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
B Rack
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
J Jueckstock
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
A Schneeweiss
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
E Thurner-Herrmanns
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
A Schneider
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
M Rezai
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
M Beckmann
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
K Pantel
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
W Lichtenegger
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
H Sommer
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
K Friese
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
W Janni
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
D Chatsiproios
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
DOI: 10.1158/0008-5472.SABCS-303 Published January 2009
  • Article
  • Info & Metrics
Loading
CTRC-AACR San Antonio Breast Cancer Symposium: 2008 Abstracts

Abstract

Abstract #303

Background:
The detection of Disseminated Tumor Cells in the Bone Marrow (BM) of Breast Cancer patients has shown prognostic significance in all stages of the disease. An alternative towards BM examination could be the analysis of peripheral blood for Circulating Tumor Cells (CTCs), which has demonstrated prognostic significance in metastatic disease. We analyzed peripheral blood samples from pts. Before and after adjuvant taxane-based chemotherapy as part of the translational research program of the German SUCCESS-trial.
Methods: Peripheral blood samples (23 ml each) from 1500 N+ and high risk N- breast cancer pts were analyzed for the presence of CTCs with the CellSearchSystem (Veridex, USA) before and after adjuvant chemotherapy. After automated immunomagnetic enrichment with an anti-Epcam-antibody, cells are labelled with anti-cytokeratin (8,18,19) and anti-CD45 antibodies to distinguish between epithelial cells and leukocytes. Samples are screened automatedly and positive events are visualised on a screen for re-evaluation.
Results: In143 pts (10 %) more than 1 CTC was detected before the start of systemic treatment (mean 14, range 2-827). 2 CTCs were found in 4 % of pts, 3 % had 3-5 CTCs and 1 % 6-10 and >10 CTCs, resp. The presence of CTCs did not correlate with tumor size (p=.32), grading (p=.36), hormonal status (p=.28) or Her2 status of the primary tumor (p=.82), but with the presence of lymph node metastases (p=.003). As negative control, three of 74 healthy individuals showed more than 1 CTC.
After completion of chemotherapy, 9 % of pts (n=130) presented with >1 CTC (mean 6, range 2-124). Of those initially CTC positive, 10% remained positive (n=15), whereas of those initially CTC negative, 8 % turned positive after chemotherapy (n=115, p=.42).
21 recurrences have been reported during a median follow-up time of 12 months, and 7 pts have died of their disease. While detection of CTCs before systemic treatment did not show prognostic relevance for DFS (p=.89) and OAS (p=.71), presence of CTCs after chemotherapy was a significant predictor for both reduced DFS (p=.04) and OAS (p=.03).
Conclusions:
Our preliminary results demonstrate prognostic relevance of the presence of CTCs after adjuvant chemotherapy for the first time. Even in the adjuvant setting as well as during follow up, the examination of CTCs could be a valuable tool for monitoring the disease and the effectiveness of therapies. Longer follow-up of the SUCCESS-trial will have to be awaited to confirm these findings.

Citation Information: Cancer Res 2009;69(2 Suppl):Abstract nr 303.

  • ©2009 American Association for Cancer Research.
Back to top
Cancer Research: 69 (2 Supplement)
January 2009
Volume 69, Issue 2 Supplement
  • Table of Contents
  • Index by Author

Sign up for alerts

Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for sharing this Cancer Research article.

NOTE: We request your email address only to inform the recipient that it was you who recommended this article, and that it is not junk mail. We do not retain these email addresses.

Enter multiple addresses on separate lines or separate them with commas.
Prognostic relevance of circulating tumor cells (CTCs) in peripheral blood of breast cancer patients before and after adjuvant chemotherapy – translational research program of the German SUCCESS-trial.
(Your Name) has forwarded a page to you from Cancer Research
(Your Name) thought you would be interested in this article in Cancer Research.
Citation Tools
Prognostic relevance of circulating tumor cells (CTCs) in peripheral blood of breast cancer patients before and after adjuvant chemotherapy – translational research program of the German SUCCESS-trial.
C Schindlbeck, B Rack, J Jueckstock, A Schneeweiss, E Thurner-Herrmanns, A Schneider, M Rezai, M Beckmann, K Pantel, W Lichtenegger, H Sommer, K Friese, W Janni and D Chatsiproios
Cancer Res January 15 2009 (69) (2 Supplement) 303; DOI: 10.1158/0008-5472.SABCS-303

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Share
Prognostic relevance of circulating tumor cells (CTCs) in peripheral blood of breast cancer patients before and after adjuvant chemotherapy – translational research program of the German SUCCESS-trial.
C Schindlbeck, B Rack, J Jueckstock, A Schneeweiss, E Thurner-Herrmanns, A Schneider, M Rezai, M Beckmann, K Pantel, W Lichtenegger, H Sommer, K Friese, W Janni and D Chatsiproios
Cancer Res January 15 2009 (69) (2 Supplement) 303; DOI: 10.1158/0008-5472.SABCS-303
del.icio.us logo Digg logo Reddit logo Twitter logo CiteULike logo Facebook logo Google logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Jump to section

  • Article
  • Info & Metrics
Advertisement

Related Articles

Cited By...

More in this TOC Section

Poster Discussion Abstracts

  • Abstract PD7-05: Comparative costs of breast cancer screening with digital breast tomosynthesis versus digital mammography: A health system perspective
  • Abstract PD4-07: Genenomic landscape of breast cancers with FGFR1 amplification and FGFR1/CCND1 co-amplification revealed by targeted capture next generation sequencing
  • Abstract PD2-08: Predictors of axillary nodal metastasis based on gene expression and clinicopathological characteristics: Data from a population-based prospective study, the Sweden Cancerome Analysis Network – Breast (SCAN-B)
Show more 3

Circulating Tumor Cells and Marrow Micro.

  • No clinical relevance of standardized immunocytological and molecular methods for detection of disseminated tumor cells in bone marrow of patients with primary breast cancer.
  • A multi-marker QPCR panel for the detection of circulating tumor cells predicts survival in breast cancer patients.
Show more 3

Marrow and Blood Micrometastase

  • No clinical relevance of standardized immunocytological and molecular methods for detection of disseminated tumor cells in bone marrow of patients with primary breast cancer.
  • A multi-marker QPCR panel for the detection of circulating tumor cells predicts survival in breast cancer patients.
  • Comparison between circulating and disseminated tumor cells in breast cancer.
Show more 3
  • Home
  • Alerts
  • Feedback
Facebook  Twitter  LinkedIn  YouTube  RSS

Articles

  • Online First
  • Current Issue
  • Past Issues
  • Meeting Abstracts

Info for

  • Authors
  • Subscribers
  • Advertisers
  • Librarians
  • Reviewers

About Cancer Research

  • About the Journal
  • Editorial Board
  • Permissions
  • Submit a Manuscript
AACR logo

Copyright © 2018 by the American Association for Cancer Research.

Cancer Research Online ISSN: 1538-7445
Cancer Research Print ISSN: 0008-5472
Journal of Cancer Research ISSN: 0099-7013
American Journal of Cancer ISSN: 0099-7374

Advertisement